Cargando…
Isolated growth hormone deficiency type IA due to a novel GH1 variant: a case report
BACKGROUND: A case of isolated growth hormone deficiency type IA (IGHD IA) caused by novel compound heterozygous mutation in the GH1 gene was reported in this study, which aimed to provide insights that will benefit future diagnosis and treatment. CASE PRESENTATION: We analyzed and summarized the cl...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411534/ https://www.ncbi.nlm.nih.gov/pubmed/34470639 http://dx.doi.org/10.1186/s12920-021-01057-z |
_version_ | 1783747313003397120 |
---|---|
author | Yang, Xi Yuan, Mingming Li, Zhuoguang Ying, Yanqin Hou, Ling Luo, Xiaoping |
author_facet | Yang, Xi Yuan, Mingming Li, Zhuoguang Ying, Yanqin Hou, Ling Luo, Xiaoping |
author_sort | Yang, Xi |
collection | PubMed |
description | BACKGROUND: A case of isolated growth hormone deficiency type IA (IGHD IA) caused by novel compound heterozygous mutation in the GH1 gene was reported in this study, which aimed to provide insights that will benefit future diagnosis and treatment. CASE PRESENTATION: We analyzed and summarized the clinical data and genetic test results from a patient with IGHD admitted in March 2019 to the Department of Pediatrics Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology. We described the results from a 1-year-9-months old female, whose chief complaint was “growth retardation for more than one year”. Her birth length was 49.0 cm, and her birth weight was 3.05 kg. Suboptimal intake (breastfeeding) jaundice lasted for approximately two months following birth. When evaluated at the age of 1-year-9-months old, the patient’s height was 61.0 cm (− 7.24 SD), and her weight was 6.4 kg (− 1.50 SD). The patient’s physical characteristics included yellowish hair, large and unclosed anterior fontanelles, raised forehead, and a low and flat nose. The major abnormalities observed from the auxiliary examinations included low GH (< 0.05 μg/l), low IGF-1 (16.99 μg/l), and elevated TSH (6.97 mIU/l). Genetic testing revealed two heterozygous variants: a splicing mutation (NG_011676.1(NM_022560.4): c.10 + 1G>T, inherited from her mother) in intron 1 of the GH1 gene and a deletion that encompassed the same gene (chr17: 61973811–61996255, inherited from her father). After hormone replacement therapy with L-thyroxine and recombinant human GH (rhGH), the patient’s thyroid function returned to normal, and her serum IGF-1 level significantly improved, which resulted in an accelerated increase in height. CONCLUSION: This study described a case of IGHD caused by novel compound heterozygous mutations in the GH1 gene. This study suggested that closer attention should be directed to genetic testing and diagnosis based on clinical characteristics to avoid misdiagnosis. |
format | Online Article Text |
id | pubmed-8411534 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-84115342021-09-09 Isolated growth hormone deficiency type IA due to a novel GH1 variant: a case report Yang, Xi Yuan, Mingming Li, Zhuoguang Ying, Yanqin Hou, Ling Luo, Xiaoping BMC Med Genomics Case Report BACKGROUND: A case of isolated growth hormone deficiency type IA (IGHD IA) caused by novel compound heterozygous mutation in the GH1 gene was reported in this study, which aimed to provide insights that will benefit future diagnosis and treatment. CASE PRESENTATION: We analyzed and summarized the clinical data and genetic test results from a patient with IGHD admitted in March 2019 to the Department of Pediatrics Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology. We described the results from a 1-year-9-months old female, whose chief complaint was “growth retardation for more than one year”. Her birth length was 49.0 cm, and her birth weight was 3.05 kg. Suboptimal intake (breastfeeding) jaundice lasted for approximately two months following birth. When evaluated at the age of 1-year-9-months old, the patient’s height was 61.0 cm (− 7.24 SD), and her weight was 6.4 kg (− 1.50 SD). The patient’s physical characteristics included yellowish hair, large and unclosed anterior fontanelles, raised forehead, and a low and flat nose. The major abnormalities observed from the auxiliary examinations included low GH (< 0.05 μg/l), low IGF-1 (16.99 μg/l), and elevated TSH (6.97 mIU/l). Genetic testing revealed two heterozygous variants: a splicing mutation (NG_011676.1(NM_022560.4): c.10 + 1G>T, inherited from her mother) in intron 1 of the GH1 gene and a deletion that encompassed the same gene (chr17: 61973811–61996255, inherited from her father). After hormone replacement therapy with L-thyroxine and recombinant human GH (rhGH), the patient’s thyroid function returned to normal, and her serum IGF-1 level significantly improved, which resulted in an accelerated increase in height. CONCLUSION: This study described a case of IGHD caused by novel compound heterozygous mutations in the GH1 gene. This study suggested that closer attention should be directed to genetic testing and diagnosis based on clinical characteristics to avoid misdiagnosis. BioMed Central 2021-09-02 /pmc/articles/PMC8411534/ /pubmed/34470639 http://dx.doi.org/10.1186/s12920-021-01057-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Case Report Yang, Xi Yuan, Mingming Li, Zhuoguang Ying, Yanqin Hou, Ling Luo, Xiaoping Isolated growth hormone deficiency type IA due to a novel GH1 variant: a case report |
title | Isolated growth hormone deficiency type IA due to a novel GH1 variant: a case report |
title_full | Isolated growth hormone deficiency type IA due to a novel GH1 variant: a case report |
title_fullStr | Isolated growth hormone deficiency type IA due to a novel GH1 variant: a case report |
title_full_unstemmed | Isolated growth hormone deficiency type IA due to a novel GH1 variant: a case report |
title_short | Isolated growth hormone deficiency type IA due to a novel GH1 variant: a case report |
title_sort | isolated growth hormone deficiency type ia due to a novel gh1 variant: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411534/ https://www.ncbi.nlm.nih.gov/pubmed/34470639 http://dx.doi.org/10.1186/s12920-021-01057-z |
work_keys_str_mv | AT yangxi isolatedgrowthhormonedeficiencytypeiaduetoanovelgh1variantacasereport AT yuanmingming isolatedgrowthhormonedeficiencytypeiaduetoanovelgh1variantacasereport AT lizhuoguang isolatedgrowthhormonedeficiencytypeiaduetoanovelgh1variantacasereport AT yingyanqin isolatedgrowthhormonedeficiencytypeiaduetoanovelgh1variantacasereport AT houling isolatedgrowthhormonedeficiencytypeiaduetoanovelgh1variantacasereport AT luoxiaoping isolatedgrowthhormonedeficiencytypeiaduetoanovelgh1variantacasereport |